VenciJVGandhiMA. Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis. Ann Pharmacotherapy. 2013;47:1697-1702.
2.
US Food and Drug Administration. FDA Drug Safety Communication: safety review of a reported death after the first dose of multiple sclerosis drug Gilenya (fingolimod). http://www.fda.gov/Drugs/DrugSafety/ucm284240.htm#data. Accessed April 8, 2014.
3.
US Food and Drug Administration. FDA Drug Safety Communication: revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod). http://www.fda.gov/Drugs/DrugSafety/ucm303192.htm#data. Accessed April 8, 2014.
4.
Data on file, Novartis Pharma AG, Basel, Switzerland.
